Last 796.15 INR
Change Today +7.50 / 0.95%
Volume 13.3K
CDH On Other Exchanges
Symbol
Exchange
Natl India
As of 7:05 AM 05/24/13 All times are local (Market data is delayed by at least 15 minutes).

cadila healthcare ltd (CDH) Snapshot

Open
783.15
Previous Close
788.65
Day High
799.00
Day Low
778.10
52 Week High
11/26/12 - 975.00
52 Week Low
06/4/12 - 705.05
Market Cap
163.0B
Average Volume 10 Days
61.2K
EPS TTM
31.87
Shares Outstanding
204.7M
EX-Date
07/26/12
P/E TM
25.0x
Dividend
7.50
Dividend Yield
0.94%
Current Stock Chart for CADILA HEALTHCARE LTD (CDH)

cadila healthcare ltd (CDH) Latest News

More News

cadila healthcare ltd (CDH) Related Businessweek News

No Related Businessweek News Found

cadila healthcare ltd (CDH) Details

Cadila Healthcare Limited discovers, develops, manufactures, and markets a range of healthcare products worldwide. It provides API, formulations, animal health products, and cosmeceuticals. The company offers products in the areas of cardiovasculars, gastro intestinals, respiratory, women’s healthcare, pain management, CNS, anti-infectives, oncology, neurosciences, dermatology, nephrology, and chronic/lifestyle primarily under the Aten, Ocid, Deriphyllin, Pantodac, Atorva, Nucoxia, and Mifegest brands. It also produces consumer healthcare and wellness products, such as Sugar Free Gold, a sweetener; Sugar Free Natura, a sucralose based sugar substitute; Sugar Free D’lite, a healthy drink; Nutralite, a cholesterol-free table spread; and Actilife, a nutritional milk additive for adults, as well as skincare products under its Everyuth and Dermacare brands. In addition, the company provides animal healthcare products comprising drugs, feed supplements, and vaccines for livestock, companion animals, and poultry. Further, it is involved in the research and development of new molecular entities, novel drug delivery systems, biologicals, and generic product development, as well as solid orals, pulmonary, parenterals, suppository, topical, and oncology products. The company was founded in 1952 and is headquartered in Ahmedabad, India.

Founded in 1952

cadila healthcare ltd (CDH) Top Compensated Officers

Chairman, Managing Director, Chairman of Comm...
Total Annual Compensation: 120.0M
Deputy Managing Director, Non Executive Direc...
Total Annual Compensation: 80.0M
Compensation as of Fiscal Year 2012.

cadila healthcare ltd (CDH) Key Developments

Cadila Healthcare Loses Prevacid SoluTab Patent Infringement Case Against Takeda

Cadila Healthcare has reportedly lost Prevacid SoluTab patent infringement case against Takeda after New Jersey court ruled in Takeda's favor in case of Lansoprazole ODT. Prevacid SoluTab is used to treat gastric ulcers. Earlier, Takeda had sued Cadila Healthcare on filing for generic ODT.

Cadila Healthcare Limited, Board Meeting, Apr 22, 2013

Cadila Healthcare Limited, Board Meeting, Apr 22, 2013. Agenda: To consider a proposal for exploring the possibilities for merger of certain wholly owned subsidiary companies with the company; and to approve the draft scheme of amalgamation under section 391-394 of the Companies Act, 1956.

Cadila Healthcare Limited Receives Tentative Approval for Amlodipine Besylate and Benazepril Hydrochloride Capsules from USFDA

Cadila Healthcare Limited announced that it received tentative approval from USFDA for Amlodipine Besylate and Benazepril Hydrochloride Capsules, in the strengths of 2.5 mg/10 mg, 5 mg/10 mg, 5 mg/20 mg and 10 mg/20 mg. It falls in the anti-hypertensive segment.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CDH:IN 796.15 INR +7.50

CDH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Dr Reddy's Laboratories Ltd 2,066 INR +14.65
View Industry Companies
 

Industry Analysis

CDH

Industry Average

Valuation CDH Industry Range
Price/Earnings 28.4x
Price/Sales 2.6x
Price/Book 5.6x
Price/Cash Flow 21.6x
TEV/Sales 2.2x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CADILA HEALTHCARE LTD, please visit www.zyduscadila.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.